keyboard_arrow_up

Personalized Medicine and Companion Diagnostic Market

ResearchMoz.us include new market research report "Personalized Medicine and Companion Diagnostic Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment "to its huge collection of research reports.

Browse Full Report With TOC At : http://www.researchmoz.us/personalized-medicine-and-companion-diagnostic-market-a-strategic-analysis-of-industry-trends-technologies-participants-and-environment-report.html

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 263 tables & figures over 224 pages. The personalized medicine (global) market is presented as follows:

• By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD)

• By Geography (US, UK, EU)

• By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services)

• By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics)

A wealth of financial data & business strategy information is provided including:

Up-to-date company financials, sales & revenue figures

Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies

Business Model Strategies for Providers. Provider Systems and Academic Medical Centres

Business Model Strategies for Payers & Governments

Private and Public Funding and Personalized Medicine Reimbursement 

Revisions to Current Payment Systems and intellectual property

How to Gain Market Penetration in the EU

Cost-effectiveness and Business Value of Personalized Medicine

Consumer genomics and POC market

Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations)

Comprehensive account of company product portfolios & kits

Browse Medical Equipment Related Reports At : http://www.researchmoz.us/medical-equipments-market-reports-109.html

SWOT, Economic & Regulatory Environment specifics include:

Key strengths, weaknesses and threats influencing leading player position within the market

Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)

Top fastest growing market segments and emerging opportunities

Top pharmaceutical companies within the IPM by market share and revenue

Comprehensive product portfolios, R&D activity and pipeline therapeutics 

M&A activity and future strategies of top personalized medicine pharmacos

Personalized Medicine Regulation (UK, Germany, France, Spain, Italy)

CE-marked Personalized Medicine/Diagnostic Tests

FDA Advances in Personalized Medicine Regulation

This report highlights a number of significant Indian pharmacos and gives details of their operations, products, financials and business strategy. 

23andMe

Affymetrix

Astex Pharmaceuticals

Atossa Genetics

CuraGen

Celera Corporation (Quest Diagnostics)

Celldex Therapeutics

deCode Genetics (Amgen)

Illumina

Genelex

Myriad 

Nodality

Qiagen

Browse All Latest Research Reports At : http://www.researchmoz.us/latest-report.html

What you will gain:

An in-depth understanding of the global personalized medicine market and it’s environment

Current market facts, figures and product lines of key players in the industry

Emerging trends in key markets such as the US, UK, Germany and France

Knowledge of how the personalized medicine market will integrate into the global healthcare market 

Technical insights into new generation sequencing technologies and ultra-high throughput sequencing

Updates on bioinformatics, high throughput systems, genetic analysis kits, companion diagnostics and future technologies

FDA approved pharmacogenetic tests and recognized biomarkers

Information on key government and regulatory policies 

Strategies on how to adapt and restructure current business models to this industry

This report tackles key concerns to the personalized medicine market such as:

Lack of regulatory policy and legislation in the US and Europe

Reimbursement schemes and payers concerns

Transition of investigational diagnostic assays and therapeutics to clinical practice

For More Information Kindly Contact:

Email: sales@researchmoz.us

Web Site: http://www.researchmoz.us/

Blog: http://deepmarketresearchreports.blogspot.com/

Blog: http://medicaldevicesmarket.blogspot.com